BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hase A, Erdmann M, Limbach V, Hasler G. Analysis of recreational psychedelic substance use experiences classified by substance. Psychopharmacology (Berl) 2022. [PMID: 35031816 DOI: 10.1007/s00213-022-06062-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Herrmann Z, Earleywine M, De Leo J, Slabaugh S, Kenny T, Rush AJ. Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials. J Psychoactive Drugs 2022;:1-17. [PMID: 36127639 DOI: 10.1080/02791072.2022.2125467] [Reference Citation Analysis]
2 Kobayashi NHC, Farias SV, Luz DA, Machado-ferraro KM, Conceição BCD, Silveira CCMD, Fernandes LMP, Cartágenes SDC, Ferreira VMM, Fontes-júnior EA, Maia CDSF. Ketamine plus Alcohol: What We Know and What We Can Expect about This. IJMS 2022;23:7800. [DOI: 10.3390/ijms23147800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Murray CH, Srinivasa-desikan B. The altered state of consciousness induced by Δ9-THC. Consciousness and Cognition 2022;102:103357. [DOI: 10.1016/j.concog.2022.103357] [Reference Citation Analysis]
4 Lawrence DW, Carhart-Harris R, Griffiths R, Timmermann C. Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience. Sci Rep 2022;12:8562. [PMID: 35610230 DOI: 10.1038/s41598-022-11999-8] [Reference Citation Analysis]
5 Hasler G. Toward the “helioscope” hypothesis of psychedelic therapy. European Neuropsychopharmacology 2022;57:118-9. [DOI: 10.1016/j.euroneuro.2022.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]